Home > News > World
Monday August 25, 2014 MYT 11:45:03 AM
Monday August 25, 2014 MYT 11:46:18 AM
TOKYO (Reuters) - Japan could offer an unapproved drug under certain circumstances to help treat the deadly Ebola virus even before the World Health Organization has decided to make a request for the drug, the country's top government spokesman said on Monday.
Chief Cabinet Secretary Yoshihide Suga told a news conference that Japan would cooperate with the WHO and was ready to make an international contribution.
"I am informed that medical professionals could make a request for T-705 in an emergency even before a decision by the WHO. In that case, we would like to respond under certain criteria," he said.
T-705 is the developmental code for the influenza drug favipiravir. Japan's Fujifilm Holdings Corp and U.S. partner MediVector are in talks with the U.S. Food and Drug Administration to submit an application to expand the use of favipiravir as a treatment for Ebola.
The Ebola epidemic in West Africa has killed more than 1,000 people and prompted the WHO to declare an international health emergency.
(Reporting by Kaori Kaneko; Editing by Chris Gallagher)
Lesotho brings forward vote to ease political crisis
Islamic State shoots down Syrian war plane - monitor group
Japan, China, South Korea finance chiefs to meet on sidelines of G20
French PM Valls mollifies rebels before confidence vote
Balkans hit by fresh flooding; three dead
Obama to send 3,000 troops to tackle Ebola
Swedish Liberals say ready to work with centre left after vote
Is HTC planning an action cam?
London’s famous residents: See how Freud, Holmes, Dickens lived
Copyright © 1995-2014 Star Publications (M) Bhd (Co No 10894-D)